(Q51032470)

27 March 2018

title

Loss of antibodies, but not of protection. (English)

1 reference

27 March 2018

author

Jürgen J Wenzel

series ordinal

1

1 reference

27 March 2018

author name string

Wolfgang Jilg

series ordinal

2

1 reference

27 March 2018

publication date

1 November 2010

1 reference

27 March 2018

Lancet Infectious Diseases

published in

1 reference

27 March 2018

volume

10

1 reference

27 March 2018

issue

11

1 reference

27 March 2018

page(s)

738-739

1 reference

27 March 2018

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type B vaccines and evaluation of booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Persistence of specific antibodies after hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970217-6

7 January 2021

10.1016/S1473-3099(10)70217-6

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

21029981

1 reference

27 March 2018